Numinus Wellness Inc.'s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M
Numinus Wellness Inc.'s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M
努米纳斯健康公司的第四季度和2022财年报告显示,收入增长了464%,达到420万美元
Numinus Wellness Inc. (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, reported its financial results late Monday for the three and twelve months ended August 31, 2022.
努米纳斯健康公司。多伦多证券交易所股票代码:NUMI)(多伦多证券交易所股票代码:NUMIF)是一家推进创新治疗和安全、循证迷幻辅助治疗的精神健康护理公司,该公司周一晚间公布了截至2022年8月31日的三个月和十二个月的财务业绩。
"Fiscal 2022 was a pivotal year for Numinus, as we entered the US market with the transformational acquisition of Novamind, expanded our Ketamine-assisted Therapy offering across Canada, launched a formal practitioner training program, and unveiled a global rebranding of our company," stated Payton Nyquvest, founder and CEO. "Combined, these efforts have provided a solid platform for our continued, measured growth – with scalable infrastructure and...
“2022财年对努米纳斯来说是关键的一年,因为我们通过对Novamind的变革性收购进入了美国市场,在加拿大扩展了我们的氯胺酮辅...
登录免费看全文
登录/注册